2012 annual financial data
Ligand Pharmaceuticals 2012 Operating cash flow growth
Direct answer
Operating cash flow growth was 113.74%.
Operating income was 574,000 USD and net income was -527,000 USD.
Operating cash flow was 161,000 USD.
Get free Ligand Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 31,388,000 USD
- Operating income
- 574,000 USD
- Net income
- -527,000 USD
- Operating cash flow
- 161,000 USD